Key result
Epicardial left atrial appendage clipping with the AtriClip device provides a safe and durable alternative for stroke prevention in patients with atrial fibrillation who are ineligible for percutaneous closure or anticoagulation.
Minimally invasive epicardial LAA clipping with AtriClip is a safe and effective alternative for stroke prevention in AF patients ineligible for percutaneous closure or oral anticoagulation.
Epicardial LAA clip occlusion may suit complex anatomy where percutaneous methods fall short; leaves open prospective trials for durable stroke prevention.
The left atrial appendage (LAA) is a key source of thrombi in patients with non-valvular atrial fibrillation (AF) and a major clinical focus for stroke prevention. Current surgical exclusion remains suboptimal and percutaneous approaches targeting the LAA, although well validated, fail to offer complete and durable occlusion for all patients. The high anatomical variability of the LAA demands a more tailored and targeted treatment approach. Epicardial LAA clip occlusion represents an important alternative approach for patients with AF not amenable to catheter closure or where anticoagulation is contraindicated. In this article, we briefly review the clinical evidence for epicardial devices in LAA occlusion, with a focus on the AtriClip and discuss their role in stroke prevention strategies.
No takes yet. Share an insight, caveat, or question.
Crijns et al. (2018) conducted a review in Non-valvular atrial fibrillation. Epicardial Left Atrial Appendage Occlusion (AtriClip) was evaluated. Epicardial left atrial appendage clipping with the AtriClip device provides a safe and durable alternative for stroke prevention in patients with atrial fibrillation who are ineligible for percutaneous closure or anticoagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: